Compare QRVO & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QRVO | ICLR |
|---|---|---|
| Founded | 1957 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 9.3B |
| IPO Year | 2014 | 2001 |
| Metric | QRVO | ICLR |
|---|---|---|
| Price | $96.41 | $161.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $90.64 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 948.7K | 527.9K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 524.14 | N/A |
| EPS | ★ 3.62 | N/A |
| Revenue | ★ $3,678,517,000.00 | N/A |
| Revenue This Year | $0.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $26.54 | ★ $12.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $75.43 | $66.57 |
| 52 Week High | $109.49 | $203.91 |
| Indicator | QRVO | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 42.40 |
| Support Level | $92.89 | $150.86 |
| Resistance Level | $99.08 | $183.11 |
| Average True Range (ATR) | 2.46 | 6.54 |
| MACD | -0.26 | -0.91 |
| Stochastic Oscillator | 59.71 | 6.75 |
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of non-smartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.